Literature DB >> 16306128

Dominant-negative effects of human P/Q-type Ca2+ channel mutations associated with episodic ataxia type 2.

Chung-Jiuan Jeng1, Yu-Ting Chen, Yi-Wen Chen, Chih-Yung Tang.   

Abstract

Episodic ataxia type 2 (EA2) is an inherited autosomal dominant disorder related to cerebellar dysfunction and is associated with mutations in the pore-forming alpha(1A)-subunits of human P/Q-type Ca(2+) channels (Cav2.1 channels). The majority of EA2 mutations result in significant loss-of-function phenotypes. Whether EA2 mutants may display dominant-negative effects in human, however, remains controversial. To address this issue, five EA2 mutants in the long isoform of human alpha(1A)-subunits were expressed in Xenopus oocytes to explore their potential dominant-negative effects. Upon coexpressing the cRNA of alpha(1A)-WT with each alpha(1A)-mutant in molar ratios ranging from 1:1 to 1:10, the amplitude of Ba(2+) currents through wild-type (WT)-Cav2.1 channels decreased significantly as the relative molar ratio of alpha(1A)-mutants increased, suggesting the presence of an alpha(1A)-mutant-specific suppression effect. When we coexpressed alpha(1A)-WT with proteins not known to interact with Cav2.1 channels, we observed no significant suppression effects. Furthermore, increasing the amount of auxiliary subunits resulted in partial reversal of the suppression effects in nonsense but not missense EA2 mutants. On the other hand, when we repeated the same coinjection experiments of alpha(1A)-WT and mutant using a splice variant of alpha(1A)-subunit that contained a considerably shorter COOH terminus (i.e., the short isoform), no significant dominant-negative effects were noted until we enhanced the relative molar ratio to 1:10. Altogether, these results indicate that for human WT-Cav2.1 channels comprising the long-alpha(1A)-subunit isoform, both missense and nonsense EA2 mutants indeed display prominent dominant-negative effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16306128     DOI: 10.1152/ajpcell.00247.2005

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  14 in total

Review 1.  Headache-type adverse effects of NO donors: vasodilation and beyond.

Authors:  G Bagdy; P Riba; V Kecskeméti; D Chase; G Juhász
Journal:  Br J Pharmacol       Date:  2010-03-19       Impact factor: 8.739

2.  Ubiquitin Ligase RNF138 Promotes Episodic Ataxia Type 2-Associated Aberrant Degradation of Human Cav2.1 (P/Q-Type) Calcium Channels.

Authors:  Ssu-Ju Fu; Chung-Jiuan Jeng; Chia-Hao Ma; Yi-Jheng Peng; Chi-Ming Lee; Ya-Ching Fang; Yi-Ching Lee; Sung-Chun Tang; Meng-Chun Hu; Chih-Yung Tang
Journal:  J Neurosci       Date:  2017-02-06       Impact factor: 6.167

3.  Dominant-negative suppression of Cav2.1 currents by alpha(1)2.1 truncations requires the conserved interaction domain for beta subunits.

Authors:  Robert S Raike; Holly B Kordasiewicz; Randall M Thompson; Christopher M Gomez
Journal:  Mol Cell Neurosci       Date:  2006-12-11       Impact factor: 4.314

4.  Clinical and genetic characterization of CACNA1A-related disease.

Authors:  Amy R Lipman; Xiao Fan; Yufeng Shen; Wendy K Chung
Journal:  Clin Genet       Date:  2022-06-26       Impact factor: 4.296

5.  Low-frequency oscillations in the cerebellar cortex of the tottering mouse.

Authors:  Gang Chen; Laurentiu S Popa; Xinming Wang; Wangcai Gao; Justin Barnes; Claudia M Hendrix; Ellen J Hess; Timothy J Ebner
Journal:  J Neurophysiol       Date:  2008-11-05       Impact factor: 2.714

6.  Novel mRNA isoforms of the sodium channels Na(v)1.2, Na(v)1.3 and Na(v)1.7 encode predicted two-domain, truncated proteins.

Authors:  N C H Kerr; F E Holmes; D Wynick
Journal:  Neuroscience       Date:  2008-05-06       Impact factor: 3.590

7.  The first knockin mouse model of episodic ataxia type 2.

Authors:  Samuel J Rose; Lisa H Kriener; Ann K Heinzer; Xueliang Fan; Robert S Raike; Arn M J M van den Maagdenberg; Ellen J Hess
Journal:  Exp Neurol       Date:  2014-08-08       Impact factor: 5.330

Review 8.  CaV2.1 channelopathies.

Authors:  Daniela Pietrobon
Journal:  Pflugers Arch       Date:  2010-03-04       Impact factor: 3.657

9.  Large Genomic Deletions in CACNA1A Cause Episodic Ataxia Type 2.

Authors:  Jijun Wan; Hafsa Mamsa; Janine L Johnston; Elizabeth L Spriggs; Harvey S Singer; David S Zee; Alhamza R Al-Bayati; Robert W Baloh; Joanna C Jen
Journal:  Front Neurol       Date:  2011-09-09       Impact factor: 4.003

10.  N terminus is key to the dominant negative suppression of Ca(V)2 calcium channels: implications for episodic ataxia type 2.

Authors:  Karen M Page; Fay Heblich; Wojciech Margas; Wendy S Pratt; Manuela Nieto-Rostro; Kanchan Chaggar; Kieran Sandhu; Anthony Davies; Annette C Dolphin
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.